Correlation between magnetic resonance imaging and histopathological tumor response after neoadjuvant chemotherapy in breast cancer

Tumori

Volumn 94, Issue 4, 2008, Pages 481-488

  Nicoletto, Maria Ornella ^a   Nitti, Donato ^b   Pescarini, Luigi ^a   Corbetti, Francesco ^c   Mencarelli, Roberto ^b   Cappetta, Alessandro ^a   Galligioni, Alessandra ^a   Pogliani, Claudia ^a   Marchet, Alberto ^b   Bozza, Fernando ^c   Ghiotto, Cristina ^a   Griggio, Luciano ^d   Zavagno, Giorgio ^b   Donach, Martin Edward ^a   Di Maggio, Cosimo ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d Ospedale Civile di Arzignano   (Italy)

Author keywords

Breast cancer; Chemotherapy; Magnetic resonance imaging; Neoadjuvant; Predictive value; Tumor response

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; HEMOPOIETIC GROWTH FACTOR; METHOTREXATE; NAVELBINE; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PREOPERATIVE EVALUATION; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 54749154015     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160809400407     Document Type: Article

References (22)

1. Fischer U, Kopka L, Grabbe E: Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology, 213: 881-888, 1999.
2. Harms SE: Integration of breast MRI in clinical trials. J Magn Reson Imaging, 13: 830-836, 2001.
3. Helvie MA, Joynt LK, Cody RL, Pierce LJ, Adler DD, Merajver SD: Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology, 198: 327-332, 1996.
4. Londero V, Bazzocchi M, Del Frate C, Puglisi F, Di Loreto C, Francescutti G, Zuiani C: Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol, 14: 1371-1379, 2004.
5. Vinnicombe SJ, MacVicar AD, Guy RL, Sloane JP, Powles TJ, Knee G, Husband JE: Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology, 198: 333-340, 1996.
6. Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E: Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol, 17: 110-119, 1999.
7. Moskovic EC, Mansi JL, King DM, Murch CR, Smith IE: Mammography in the assessment of response to medical treatment of large primary breast cancer. Clin Radiol, 47: 339-344, 1993.
8. Schelfout K, Van Goethem M, Kersschot E, Colpaert C, Schelfhout AM, Leyman P, Verslegers I, Biltjes I, Van Den Haute J, Gillardin JP: Contrast enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol, 30: 501-507, 2004.
9. Gilles R, Guinebretiere JM, Toussaint C, Spielman M, Rietjens M, Petit JY, Contesso G, Masselot J, Vanel D: Locally advanced breast cancer: contrast enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology, 191: 633-638, 1994.
10. Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Kuhn T: Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol, 12: 1711-1719, 2002.
11. Boetes C, Mus RD, Holland R, Barentsz JO, Strijk SP, Wobbes T, Hendriks JH, Ruys SH: Breast tumours: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology, 197: 743-747, 1995.
12. Mumtaz H, Hall-Craggs MA, Davidson T, Walmsley K, Thurell W, Kissin MW, Taylor I: Staging of symptomatic primary breast cancer with MR imaging. Am J Roentgenol, 169: 417-424, 1997.
13. Kaiser WA, Zeitler E: MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology, 170(3 Pt 1): 681-686, 1989.
14. Rieber A, Merkle E, Bohm W, Brambs HJ, Tomczak R: MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr, 21: 773-779, 1997.
15. Oellinger H, Heins S, Sander B, Schoenegg W, Flesch U, Meissner R, Felix R: Gd-DTPA enhanced MRI of breast: the most sensitive method for detecting multicentric carcinomas in female breast? Eur Radiol, 3: 223-226, 1993.
16. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV: MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology, 187: 493-501, 1993.
17. Warren RM, Bobrow LG, Earl HM, Britton PD, Gopalan D, Purushotham AD, Wishart GC, Benson JR, Hollingworth W: Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer, 90: 1349-1360, 2004.
18. Mussurakis S, Buckley DL, Horsman A: Dynamic MR imag-ing of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol, 70: 446-451, 1997.
19. Stomper PC, Winston JS, Herman S, Klippenstein DL, Arredondo MA, Blumenson LE: Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat, 45: 39-46, 1997.
20. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC: New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst, 92: 205-216, 2000.
21. Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Kuhn T: Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur Radiol, 12: 1711-1719, 2002.
22. Denis F, Desbiez-Bourcier A, Chapiron C, Arbionn F, Body G, Brunereau L: Contrast-enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel-based chemotherapy for breast cancer. Eur J Surg Oncol, 30: 1069-1076, 2004.